BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15451514)

  • 1. Regulation of ryanodine receptors by FK506 binding proteins.
    Chelu MG; Danila CI; Gilman CP; Hamilton SL
    Trends Cardiovasc Med; 2004 Aug; 14(6):227-34. PubMed ID: 15451514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ
    J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ryanodine receptor channelopathies.
    Benkusky NA; Farrell EF; Valdivia HH
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1280-5. PubMed ID: 15336975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
    Kontula K; Laitinen PJ; Lehtonen A; Toivonen L; Viitasalo M; Swan H
    Cardiovasc Res; 2005 Aug; 67(3):379-87. PubMed ID: 15913575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of FKBP12/12.6 from endothelial ryanodine receptors leads to an intracellular calcium leak and endothelial dysfunction.
    Long C; Cook LG; Wu GY; Mitchell BM
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1580-6. PubMed ID: 17478757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
    George CH; Higgs GV; Lai FA
    Circ Res; 2003 Sep; 93(6):531-40. PubMed ID: 12919952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death.
    Marks AR
    J Mol Cell Cardiol; 2001 Apr; 33(4):615-24. PubMed ID: 11273716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of FK-506 binding protein 12.0 modulates excitation contraction coupling in adult rabbit ventricular cardiomyocytes.
    Seidler T; Loughrey CM; Zibrova D; Kettlewell S; Teucher N; Kögler H; Hasenfuss G; Smith GL
    Circ Res; 2007 Nov; 101(10):1020-9. PubMed ID: 17872463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of FKBP does not affect the interaction between isolated ryanodine receptors.
    Hu XF; Liang X; Chen KY; Zhu PH; Hu J
    Biochem Biophys Res Commun; 2005 Oct; 336(1):128-33. PubMed ID: 16125143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death.
    Jiang D; Wang R; Xiao B; Kong H; Hunt DJ; Choi P; Zhang L; Chen SR
    Circ Res; 2005 Nov; 97(11):1173-81. PubMed ID: 16239587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central domain of the human cardiac muscle ryanodine receptor does not mediate interaction with FKBP12.6.
    Zissimopoulos S; Lai FA
    Cell Biochem Biophys; 2005; 43(2):203-19. PubMed ID: 16049346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.
    Reiken S; Wehrens XH; Vest JA; Barbone A; Klotz S; Mancini D; Burkhoff D; Marks AR
    Circulation; 2003 May; 107(19):2459-66. PubMed ID: 12743001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal ryanodine receptor function in heart failure.
    Yano M; Yamamoto T; Ikemoto N; Matsuzaki M
    Pharmacol Ther; 2005 Sep; 107(3):377-91. PubMed ID: 15951021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 12 kDa FK506-binding protein, FKBP12, modulates the Ca(2+)-flux properties of the type-3 ryanodine receptor.
    Van Acker K; Bultynck G; Rossi D; Sorrentino V; Boens N; Missiaen L; De Smedt H; Parys JB; Callewaert G
    J Cell Sci; 2004 Mar; 117(Pt 7):1129-37. PubMed ID: 14970260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardiac ryanodine receptor (RyR2) and its role in heart disease.
    Taur Y; Frishman WH
    Cardiol Rev; 2005; 13(3):142-6. PubMed ID: 15831148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FKBP12.6 binding of ryanodine receptors carrying mutations associated with arrhythmogenic cardiac disease.
    Zissimopoulos S; Thomas NL; Jamaluddin WW; Lai FA
    Biochem J; 2009 Apr; 419(2):273-8. PubMed ID: 19226252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryanodine receptor binding to FKBP12 is modulated by channel activation state.
    Jones JL; Reynolds DF; Lai FA; Blayney LM
    J Cell Sci; 2005 Oct; 118(Pt 20):4613-9. PubMed ID: 16176935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of FKBP12.6 in hypoxia- and norepinephrine-induced Ca2+ release and contraction in pulmonary artery myocytes.
    Zheng YM; Mei QB; Wang QS; Abdullaev I; Lai FA; Xin HB; Kotlikoff MI; Wang YX
    Cell Calcium; 2004 Apr; 35(4):345-55. PubMed ID: 15036951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 ryanodine receptor domain A contains a unique and dynamic α-helix that transitions to a β-strand in a mutant linked with a heritable cardiomyopathy.
    Amador FJ; Kimlicka L; Stathopulos PB; Gasmi-Seabrook GM; Maclennan DH; Van Petegem F; Ikura M
    J Mol Biol; 2013 Nov; 425(21):4034-46. PubMed ID: 23978697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac ryanodine receptor function and regulation in heart disease.
    Lehnart SE; Wehrens XH; Kushnir A; Marks AR
    Ann N Y Acad Sci; 2004 May; 1015():144-59. PubMed ID: 15201156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.